Status:
COMPLETED
11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The number of metastases may reflect the biological aggressiveness of the tumor and may determine the possibility of performing potential curative interventions such as surgery or high-dose targeted r...
Eligibility Criteria
Inclusion
- patients diagnosed with less than 3 bone lesions found on C11-Choline PET/CT
- availability of clinical follow-up using serial PSA assays.
Exclusion
- \<18 years patients
Key Trial Info
Start Date :
October 27 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 25 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06179706
Start Date
October 27 2015
End Date
November 25 2015
Last Update
March 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italy